<DOC>
	<DOCNO>NCT01729507</DOCNO>
	<brief_summary>As add-on treatment behavioural therapy tobacco dependence , anodal transcranial direct current stimulation ( tDCS ) significantly increase cessation rate compare treatment sham tDCS ; endpoint analysis perform 1 , 3 , 6 12 month completion smoke-free programme combination tDCS . Craving , assess visual analog scale ( VAS ) , reduce significantly verum treatment group compare sham tDCS group . tDCS suitable use large group ( 8-12 people ) .</brief_summary>
	<brief_title>tDCS Add Therapy Treatment Tobacco Dependence Standardized Behaviour Therapy</brief_title>
	<detailed_description>1 . General design study population Controlled , randomise , double-blind study crossover ; sample size estimate : 20-36 participant . Sample size calculation necessary pilot study . A general 'rule thumb ' use 30 patient . An interim analysis data perform completion second course ( stimulation 24 patient ) . We reserve right increase sample size 12-24 , depend effect size , data 30 participant per arm estimate reliable . Study participant recruit via newspaper advertisement , advertisement internet page tobacco outpatient clinic announcement notice board Department Psychiatry . Study duration : estimate 12 day require patient complete study protocol . The total study duration 36 patient estimate 12 month . 2 . Screening No screening investigation perform . 3 . Randomisation blind Patients randomise two group 10-18 patient . One group receive 7x verum treatment tDSC , 7x sham treatment . All participant receive standardise behavioural therapy ( 'The smoke-free programme ' ) . Both patient clinical raters blind treatment condition . Unblinding take place completion study whole study discontinue severe incident . 4 . Experimental paradigm Up 12 participant ( maximum number participant smoke-free programme ) stimulate per course . A total 3x12 participant stimulate study subsequently participate certified behavioural therapy 'Smoke-free programme ' Gradl , S. Kröger , C. ( 2008 ) . Blinding perform start study . Every participant give number ( pseudonym ) , program stimulator . Each number randomly assign sham verum treatment treatment perform every session . The stimulator program beforehand assign number randomly verum sham group , respective patient data unknown person performs stimulation course leader . Half participant randomly assign sham group half verum group . The stimulator program start study . Stimulation perform DC stimulator MC ( neuroConn GmbH , Ilmenau , Germany ) . The stimulator micro-processor-controlled constant current source 16 freely programmable independent channel . The maximum current strength 5 mA maximum stimulation duration 30 minute . The stimulator CE-certified medical product use various national international study . The current transmitted via sponge electrode ( 35 cm2 ) soak physiological salt solution . The electrode attach head elasticated band . Location stimulation : Anode leave dorsolateral cortex , correspond F3 ( 10-20 EEG system ) ; cathode right temporal cortex ; Intensity : 2 mA ; Total duration : Constant stimulation 20 minute , plus 15 second ramp-in ramp-out phase current regulate , respectively . Stimulation time schedule : Each participant stimulate total 7 time 7 week . The stimulation follow 90-minute session 'Smoke-free programme ' . The standardised behavioural therapy perform accord certify `` Smoke-free programme ' Institute Therapy Research ( 'Institut für Therapieforschung ' , IFT ) . The course leader ' manual specifies ideal number participant 8-12 . IFT 6-week course Schedule : Duration : 7 week 1 group session 90 minutes/week 7 week 2 telephone call 10 minute , first fourth session 3 day collective smoking cessation , second day 3 last session . Study procedure : - 1st session : Smoking smoke-free life - 2nd session : The smoker 's ambivalence - 3rd session : Errors reason alternative - 4th session : Preparing quit smoke SMOKING CESSATION - 1st telephone call : Individual telephone support - 5th session : Experiences quit smoke - 6th session : Identity smoke-free person - 7th session : Planning future - 2nd telephone call : Individual telephone support 5 . Evaluation scale - Edinburgh Handedness Test : Test ass left- right-handedness evaluate dominant hemisphere . - Comfort Rating Questionnaire : Questionnaire record symptoms tDCS - Fagerström Test : Questionnaire evaluate physical tobacco dependence - Questionnaire Smoking Urges ( Tiffany &amp; Drobes , 1991 ) ( German version : Müller , Mucha , Ackermann &amp; Pauli , 2001 ) : Uses two scale measure crave cigarette . 6 . Additional evaluation As additional evaluation , start stimulation four follow-up appointment salivary cotinine ( degradation product tobacco ) carbon monoxide content expire air measure . Carbon monoxide measure Micro Smokerlyzer ( Bedfont Scientific Ltd. , Maidstone , England ) . At end tDCS treatment , study participant complete Comfort Rating Questionnaire ( CRQ ) . Our research group use questionnaire direct current stimulation several year continually improve update . The questionnaire record unpleasant sensation side effect direct current stimulation . 7 . Sample size estimate Sample size estimation study design correspond usual procedure comparable pilot study ( e.g . tDCS TMS ) . 8 . Statistical analysis Data analyse multivariate analysis covariance ( MANCOVA ) . The absolute value evaluation scale dependent variable treatment condition independent factor .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<criteria>Inclusion criterion : Age legal majority Smoker &gt; 1 year , &gt; 10 cigarettes/day CO &gt; 10ppm ; measurement expire air mean Micro Smokerlyzer ( Bedfont Scientific Ltd. , Maidstone , England ) Quantification tobacco dependence Fagerström Test The patient attempt quit smoking receive drug treatment quit smoke least 3 month start study Ability give informed consent Acute psychiatric disorder accord ISD10/DSMIV Under legal care Pregnancy Contraceptive method Pearl Index &gt; 1 Other severe psychiatric disorder Acute suicidality Drug , medication alcohol abuse time study Dementia ( DSMIV/ICD10 criterion ) History severe craniocerebral trauma Indications structural damage basal ganglion brain stem Severe neurological disorder ( prolapsed disk past 6 month , polyneuropathy , Parkinson syndrome , epilepsy , dementia , systemic neurological disease , cerebrovascular disease , history stroke , repeat cerebral ischaemia progressive worsening , elevate cerebral pressure , normal pressure hydrocephalus ) Severe medical disorder ( manifest arterial hypertension , severe cardiovascular disorder , cardiac pacemaker , respiratory insufficiency ) Any electronic implant Malignant disease kind , also medical history Severe active infectious disease Chronic systemic skin diseases Bone disease ( Paget 's disease , osteoporosis spontaneous fracture , fresh fracture )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Add smoke cessation</keyword>
	<keyword>Therapy tobacco dependence</keyword>
	<keyword>Transcranial direct current stimulation</keyword>
</DOC>